Introduction 70
Receptor-activator of nuclear factor kB ligand (RANKL), the membrane receptor RANK 71 and the soluble decoy receptor osteoprotegerin (OPG) are members of the tumor necrosis 72 factor (TNF) superfamily that regulate bone remodelling (26, 29) . RANK/RANKL 73 interaction activates Ca 2+ -dependent and NF-kB signalling pathways, which affect osteoclast 74 differentiation, activation and survival (29) . The third protagonist, OPG, binds to RANKL 75 and inhibits the RANK/RANKL interaction and subsequent osteoclastogenesis (46, 55) . In 76 addition to bone, RANK/RANKL has been detected in other tissues such as thymus, heart, 77 kidney, liver, brain, blood vessels and skeletal muscles (17, 32, 51) . The RANK/RANKL 78 pathway is known to be involved in a variety of physiological and pathological conditions 79 such as lymph-node organogenesis, formation of lactating mammary gland, breast cancer, 80 central thermoregulation, T-cell/dendritic cell communication, vascular calcification, and 81 bone metastasis (18, 36, 38, 41, 45) . 82
83
Muscle hypertrophy/atrophy and gain/loss of bone mineral density occur in parallel in 84 many physiological or pathological conditions and endocrine, mechanical factors, 85 inflammatory and nutritional states affect simultaneously skeletal muscle and bone 86 metabolism (3, 4, 16, 22, 39) . These observations are consistent with the view that skeletal 87 muscle and bone share common cell signalling pathways. For example, the Wnt/β-catenin 88 signalling pathway is a major regulator of bone mass and muscle development and growth 89 (24). Conditional deletion of Ctnnb1 gene in osteocytes, which encodes for β-catenin, leads 90 to impaired bone maturation and mineralization with increased RANKL:OPG ratio (27). In 91 bone, RANKL/RANK interactions activate tumour necrosis factor receptor-associated factors 92 6 (TRAF-6), which subsequently induces the activation of downstream signalling molecules 93 and intracellular calcium concentration ([Ca 2+ ] i ) oscillations (53 ] i 95 oscillations and plays a critical role in osteoclastogenesis (54). Moreover, it has been shown 96 that TRAF-6 is required for functional bone resorption and muscle-specific TRAF-6 deletion 97 preserves function and reduces atrophy in a model of muscle wasting indicating that TRAF-6 98 is an important regulator of both bone and muscle masses (19, 49, 50) . Thus, common 99 signalling pathways are emerging to explain the synchronicity between bone and skeletal 100 muscle physiology and pathophysiology. 101
102
Muscle contraction involves the depolarization of the transverse-tubular (t) system, which 103 activates dihydropyridine receptors (DHPRs) opening ryanodine receptor/Ca 2+ release 104 channels (RYR1) in the sarcoplasmic reticulum (SR) membrane. This results in the rapid 105 influx of Ca 2+ into the cytoplasm through RYR1 and binding of Ca 2+ ions to troponin C 106 causing the formation of actin-myosin cross-bridges and force development (34). Calcium 107 reuptake in the SR is a tightly control mechanism mediated almost exclusively by SERCA-1a 108 in fast-twitch fibers and SERCA-2a in slow-twitch fibers. The regulation of Ca 2+ is also 109 implicated in other physiological processes such as the maintenance and adaptation of muscle 110 phenotypes (7, 40) , while chronic rise in [Ca 2+ ] i is associated with different pathological 111 states including muscle dystrophy (1) and the triggering of apoptotic processes (12, 42) . 112 Therefore, the appropriate regulation of [Ca 2+ ] i is a requirement for proper cell function, 113 phenotype and survival. 114
115
We recently reported that OPG treatments protect against muscular dystrophy suggesting a 116 potential role for RANK/RANKL/OPG pathway in muscle disease. In addition, muscle 117 specific TRAF-6 deletion prevented muscle atrophy and decreased the expression of 118 ubiquitin-proteasome components in models of denervation or starvation (28, 50 attached to an electrode and a force sensor (305B-LR, Aurora Scientific, Inc.) to assess 166 contractile properties as described previously (9, 44). Muscle fatigability was examined by 167 stimulating muscle for 200 ms every second at 50 Hz until muscles lost 30% (Sol) or 50% 168 (EDL) of their initial force. Lastly, muscle length was measured, tendons were removed and 169 muscles weighed for calculation of muscle cross-sectional area and specific force (13). , ranging between 7.6 and 4.7 pCa units 229 in the presence and absence of ionophore A23187 (4.2 μM). In the absence of the ionophore, 230
Ca
2+ accumulates inside the SR vesicle and causes back-inhibition of SERCA pumps, which 231 is more relevant to the physiological system found in skeletal muscle. Aliquots (100 μl) were 232 then transferred in duplicate to a clear bottom 96-well plate (Costar, Corning Incorporated, 233 NY), where 0.3 mM NADH was added to start the reaction. The plate was read at a 234 wavelength of 340 nm for 30 min at 37°C. The different concentrations of Ca 2+ in the wells 235 were used to determine the maximal enzyme activity (Vmax) and pCa50, which is defined as 236
]f required to achieve 50% of Vmax. Lastly, cyclopiazonic acid (CPA; 40 μM), a 237 highly specific SERCA inhibitor, was used to determine background activity which was 238 subtracted from the total Ca 2+-ATPase activity measured in muscle homogenate. All data 239
were then plotted against the negative logarithm of [Ca 2+ ]f (pCa) using basic statistatical 240 software (GraphPad PrismTM version 4) to determine Vmax and pCa50. pCa50 was 241 determined by non-linear regression curve fitting using the sigmoidal dose response. To assess RANK expression in muscle cells, we first analysed its expression in C2C12 254 myoblasts and differentiated myotubes. RANK was found to be expressed in C2C12 255 myotubes but not in proliferating C2C12 myoblasts (Fig. 1a) . We next analysed RANK 256 expression in skeletal muscle cells in situ using confocal microscopy. Confocal 257 immunofluorescence confirmed the presence of RANK protein on the membrane of fast-258 twitch (EDL) (Fig. 1b) and slow-twitch (Sol; data not shown) skeletal muscle fibers. To 259 confirm specific RANK expression in muscle, we crossed RANK f/f mice onto a muscle 260 creatine kinase-Cre background to generate muscle-specific RANK knockout mice (RANK mko 261 mice). PCR results validated the deletion of the RANK allele specifically in skeletal muscle 262 tissue and partially in heart (Fig. 1c) . Deletion efficiency was confirmed at the protein level 263 in skeletal muscles where RANK immunostaining was not detectable (Fig. 1b) . 264
265

RANK deletion affects denervated muscle mass and function 266
To examine the role of RANK/RANKL in muscle pathophysiology, muscle mass, 267 contractile properties and fiber type proportions were examined in sham and denervated Sol 268 and EDL muscles from RANK f/f and RANK mko mice. Denervation and/or RANK deletion did 269 not influence mouse body weight. Treatment, but not genotype, reduced EDL and Sol muscle 270 masses when normalized to body weights (Table 1) . Intriguingly, denervated EDL muscles 271 from RANK mko mice exhibited inotropic effects as determined by the decrease in muscle mass 272 (Fig. 2a) , combined with the partial preservation of maximum specific force (sP 0 ; N/cm 2 ) 273 compared to denervated RANK f/f muscles (Fig. 2b) . The absolute force production (P 0 ; g) was 274
not different between RANK f/f and RANK mko EDL muscle but RANK deletion prevented the 275 loss of twitch tension (P t ) in denervated EDL muscles ( Table 2 ). The contractile properties of 276 control mice were similar between both genotypes (Table 2) . Lastly, the P t /P 0 ratio was 277 increased in both Sol and EDL muscles of denervated RANK mko mice (Fig. 2c) , suggesting a 278 change in myofilament Ca 2+ sensitivity and/or SR Ca 2+ release. 279 280 Denervation led to decreased fatigue resistance in both Sol and EDL muscles during a 281 repetitive and glycolytic fatigue protocol (Fig. 2d,e (Fig. 2d,e ). In accordance with the higher fatigability, immunohistochemical fiber 284 typing showed that the slow-twitch fibers were nearly absent in sham RANK mko EDL muscles 285 while the proportion of fast-twitch fibers (IIA+IIX+IIB) was significantly increased in 286 denervated RANK mko EDL muscles compared to denervated RANK f/f EDL muscles (Fig. 2f) . 287
The proportion of fiber type over 100% in denervated RANK mko EDL muscles indicated the 288 presence of hybrid fibers expressing multiple isoforms of MyHC. No changes in muscle fiber 289 type were observed in Sol muscles (Fig. 3a) indicating that the impact of muscle RANK 290 deletion on muscle fatigue and phenotype is limited to fast-twitch EDL muscles. Noticeably, 291 the proportion of fast-twitch fibers expressing SERCA-1a was reduced and the proportion of 292 fast-twitch fibers expressing SERCA-2a was increased in RANK mko Sol and EDL muscles 293 (Fig 3b) . where the highest values of [CaT] are seen with the lowest muscle weights (30). Since 298 RANK deletion promotes muscle atrophy and prevents force deficits in denervated muscles, 299 we next measured [CaT] in EDL muscles (Fig. 4a-c [CaT] and muscle weights, we found that muscle weights below <4.5 304 mg had much greater [CaT] than the bigger muscles, but data were non-linear due to a floor 305 effect in the assay (Fig. 4b) . Consistent with the reduced muscle mass in denervated RANK mko 306 EDL muscles (Fig. 2a) , [CaT] increased by 93% in denervated RANK mko EDL muscles while 307 it did not significantly increase in denervated RANK f/f EDL muscles (Fig. 4c) . 308
309
Since SERCA is critical for Ca 2+ cycling in the SR, we analyzed SERCA1a and SERCA2a 310 expression and SERCA activity in Sol and EDL muscle extracts. Western blotting analyses 311
show that SERCA1a content is significantly reduced in denervated muscles while SERCA2a 312 content is significantly increased following denervation, independently of the genotype (Fig  313   4d) . No difference in calsequestrin content, a calcium binding protein located in SR, was 314 observed between RANK f/f and RANK mko muscles (Fig 4d) . However, the content of the 315 stromal interaction molecule 1 (Stim1), which functions as a calcium sensor in the SR, 316 increased by 77% and 411% in denervated RANK f/f and RANK mko EDL muscles, relative to 317 their respective sham (Fig 4d) to pCa 4.5. Interestingly, upon denervation, maximal SERCA activity was reduced in both 322 the Sol and EDL muscles (Fig. 4e-g and Fig. 5) . Moreover, maximal SERCA activity was 323 significantly reduced in both the sham and denervated RANK mko EDL compared to the sham 324 and denervated RANK f/f EDL (Fig. 4c-f We previously demonstrated that systemic injection of OPG, the decoy receptor of 333 RANKL, restores muscle force and improves muscle histology in dystrophic mdx mice (9). 334
However, whether the RANK/RANKL/OPG system directly or indirectly affects skeletal 335 muscle was unknown. In this paper, using muscle specific RANK mutant mice, we 336 demonstrate that RANK is expressed in skeletal muscle cells where it directly regulates 337 muscle function. Importantly, muscle-specific RANK deletion protects from denervation-338 induced loss of muscle force and modulates total Ca 2+ storage and SERCA activity. 339 340 RANK is well characterized in osteoclasts where it leads to the activation of different 341 signalling pathways, especially NF-kB and calcium-dependent pathways (5). In skeletal 342 muscle, Ca 2+ is a master regulator of multiple intracellular processes such as myosin-actin 343 cross-bridging, protein synthesis and degradation, mitochondrial adaptation and fiber type 344 shifting, through the control of Ca 2+ sensitive proteases and transcriptional factors such as 345 NFATc1 (2). Consistent with a role of RANK in the regulation of calcium handling, 346 conditional deletion of RANK in skeletal muscle affected muscle contraction post-347 denervation, atrophy and fiber type, all of which are regulated by Ca 2+ (2). Intriguingly, 348 muscle-specific RANK deletion prevents the loss of specific force production but not the loss 349 of muscle mass following denervation. Without significant changes in muscle mass, muscle 350 strength can be altered by (1) 
Perspective and conclusion 415
Osteoporosis and muscle wasting occur simultaneously in a variety of pathologies, 416 although common signalling pathways between these two processes were not identified (Fig.  417   6) . Here, we show that in addition to its role in bone homeostasis, RANK signalling also 418 regulates Ca 2+ storage, muscle mass, and muscle performance. Muscle-specific deletion of 419 RANK has an inotropic effect on denervated fast-twitch EDL muscles, largely composed of 420 type IIA, IIX, and IIB fibers. Fast-twitch fibers are usually the first to be affected in several 421 forms of muscular and neuromuscular diseases and aging conditions, leading to premature 422 loss of function and important incapacities (8). Our findings show for the first time that fast-423 twitch fibers may be specifically targeted to enhance their force production. Although these 424 results are preliminary and the long-term effects remain to be determined, this discovery 425 opens a whole new field of research and new therapeutics avenues for conditions affecting in 426 synchrony bone and skeletal muscle and potentially heart diseases. 
